$APPBullishMed

Why Morgan Stanley Is Betting That $1,100 Is in Store for AppLovin Stock

AppLovin shares rebounded after Morgan Stanley reiterated a bullish view, saying improving ad conversion could support a $1,100 bull-case valuation. The stock is down 9.97% YTD but rose 24.85% in five days. After Q1 FY2026 results, revenue rose 59% to $1.8B and net income more than doubled to $1.2B. Morgan Stanley’s stance and raised targets (e.g., Piper to $665) matter amid an SEC-probe overhang.

9/10
6/10
Med
Bullish
post-earnings positioning after recent 5-day surge and Morgan Stanley reiteration
aligns with positive Street sentiment (Strong Buy consensus; multiple raised targets) despite lingering SEC-probe risk

Near-term momentum is reinforced by strong Q1 results and upbeat Q2 guidance, but the SEC-probe risk keeps downside tail risk elevated.

Morgan Stanley reiterated a bullish view that AppLovin’s ad-conversion improvements could support a $1,100 bull-case valuation amid SEC-probe overhang.

Bull-case framing and guidance support further upside attempts, though volatility likely remains high due to SEC-probe concerns.

Background

AppLovin has been under pressure YTD due to concerns about an SEC probe, but recently rebounded sharply after broker optimism and strong Q1 performance.

Why it matters

The article ties the price action to (1) strong reported Q1 fundamentals, (2) explicit Q2 guidance ranges, and (3) Morgan Stanley’s bull-case valuation anchored to ad-conversion improvements within AXON AI advertising.

Market relevance

Fundamental upside catalysts (Q1 beat + Q2 guidance) and renewed bull-case valuation likely support momentum, but SEC-probe fears can keep volatility elevated.

Market effects

Reinforces the narrative that AI-driven ad platforms can sustain high growth/margins, supporting sentiment for high-growth tech ad-tech names.

Primarily US growth-tech sentiment; could influence US small/mid-cap growth risk appetite given the stock’s sharp rebound.

Limited direct global linkage beyond broader appetite for AI advertising/monetization stories.

Alternative perspectives

The stock’s premium multiple and SEC-probe overhang raise the odds that any incremental regulatory headline could overwhelm fundamentals and compress valuation quickly.

Ad-conversion improvement is the key bull-case driver; traders should watch for any evidence that conversion gains are slowing or that guidance margins are less durable than assumed.

Key entities

  • AppLovin

    Subject of the article; strong Q1 results, upbeat Q2 guidance, and broker bull-case valuation discussion.

  • Morgan Stanley

    Reiterated bullish outlook and $1,100 bull-case valuation tied to ad conversion improvements.

  • Piper Sandler

    Raised price target to $665 from $650 while maintaining Overweight.

  • Wolfe Research

    Raised price target to $580 from $575 while reiterating Outperform.

Related articles

$TTDLow

Trade Desk Is Down 44% This Year and AppLovin Is Down 17%. Are Ad-Tech Stocks Dead Money in 2026?

Ad-tech stocks have fallen in 2026: Trade Desk is down 44% YTD near $21, while AppLovin is down 17% near $561. Trade Desk reported Q1 2026 revenue growth of 12% YoY, adjusted EBITDA margin down to 30%, and non-GAAP diluted EPS of $0.28; AppLovin reported Q1 2026 revenue up 24% YoY to $1.84B, net income up 109%, and adjusted EBITDA margin at 85%, with Q2 2026 guidance of $1.92B–$1.95B.

$APPLow

AppLovin (NASDAQ: APP), Lumentum Holdings (NASDAQ: LITE), And Oracle (NYSE: ORCL) Trade At Significant Discounts

AppLovin (APP), Lumentum (LITE) and Oracle (ORCL) were flagged in a June 2026 cash-flow analysis as trading below estimated fair value. AppLovin is said to be >30% under fair value (30.8% discount); it reported Q1 2026 sales of $1.84B and net income of $1.21B. Lumentum is estimated at a 31.5% discount after $808.4M quarterly sales and $144.2M net income. Oracle trades at $244.58 vs a $482.18 cash-flow value (~49.3% discount).

$APPLow

Is AppLovin the Most Misunderstood AI Stock on the Market?

AppLovin, formerly tied to gaming advertising, is repositioning as a high-margin AI software company, according to the article. It cites Axon 2, the sale of its gaming business, and an expansion into e-commerce as key drivers. The piece notes the stock’s recent strong run and AppLovin’s debt as factors investors may monitor.

$QCOMLow

Trade These Stocks Moving the Most

The article highlights high-momentum moves in tech stocks. Qualcomm (QCOM) rose 17% and Micron (MU) gained 32% over the past week, while Zscaler (ZS) fell 31% to $127.28, returning to early-April levels after a strong Q3 but a FY2027 outlook that pressured shares. AppLovin (APP) climbed 9.93% to $565.31 after Morgan Stanley set a $720 target, citing improved ad conversion efficiency.

$UALMedAI 9/10

Stocks Settle Mixed on Conflicting US-Iran Signals

Stocks ended mixed as markets weighed conflicting US-Iran signals. The IEA said global oil inventories fell about 4 million bpd in March-April and remain “severely undersupplied” until October even if conflict ends next month; Goldman estimates nearly 500 million bbl drawn from crude stocks. S&P 500 Q1 earnings beat rates were 83% (of 475 firms). WTI fell over 5%, lifting airlines while energy stocks declined.

$APPMedAI 8/10

AppLovin (NASDAQ:APP) Shares Up 11.7% – What’s Next?

AppLovin shares (NASDAQ:APP) rose 11.7% Tuesday to about $538 after closing at $481.68; the stock traded as high as $538.34 on lighter-than-average volume. The move followed analyst actions: Morgan Stanley reiterated Overweight with a $720 target, Needham raised its target to $700, and Deutsche Bank lifted to $660. The company’s May 6 results showed revenue up 58.9% to $1.84B and EPS of $3.56 vs $3.44 expected.